Provider of enterprise-grade messaging services. The company offers a secure mobile messaging platform and mobile application that provides mobile and Web-based secure messaging and allows enterprises, hospitals and physician groups to create their own private mobile messaging network for physicians, nurses and administrators.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/08/2020 | Series D-2 | $3.6MM | $xx.xx | $366.32MM | HealthQuest Capital, New Leaf Ventures, Montreux Growth Partners, Norwest Venture Partners, Invus, Industry Ventures | |
Price per Share
$xx.xx
Shares Outstanding
2,737,831
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
20.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
HealthQuest Capital, New Leaf Ventures, Montreux Growth Partners, Norwest Venture Partners, Invus, Industry Ventures
|
||||||
10/08/2020 | Series D-1 | $41.5MM | $xx.xx | $366.32MM | HealthQuest Capital, New Leaf Ventures, Montreux Growth Partners, Norwest Venture Partners, Invus, Industry Ventures | |
Price per Share
$xx.xx
Shares Outstanding
9,880,398
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
HealthQuest Capital, New Leaf Ventures, Montreux Growth Partners, Norwest Venture Partners, Invus, Industry Ventures
|
||||||
11/12/2015 | Series C-1 | $12.93MM | $xx.xx | $188.83MM | Norwest Venture Partners, Shasta Ventures, OrbiMed, Reed Elsevier, Invus Group, Accolade Partners | |
Price per Share
$xx.xx
Shares Outstanding
5,213,388
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Norwest Venture Partners, Shasta Ventures, OrbiMed, Reed Elsevier, Invus Group, Accolade Partners
|
||||||
11/12/2015 | Series C | $33.31MM | $xx.xx | $188.83MM | Norwest Venture Partners, Shasta Ventures, OrbiMed, Reed Elsevier, Invus Group, Accolade Partners | |
Price per Share
$xx.xx
Shares Outstanding
14,243,885
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Norwest Venture Partners, Shasta Ventures, OrbiMed, Reed Elsevier, Invus Group, Accolade Partners
|
||||||
01/27/2014 | Series B | $23.42MM | $xx.xx | $61.79MM | Shasta Ventures, OrbiMed, Reed Elsevier Ventures, TELUS Corporation, Easton Capital, New Leaf Venture Partners, New Science Ventures | |
Price per Share
$xx.xx
Shares Outstanding
17,512,573
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Shasta Ventures, OrbiMed, Reed Elsevier Ventures, TELUS Corporation, Easton Capital, New Leaf Venture Partners, New Science Ventures
|
||||||
03/14/2013 | Series A | $11.62MM | $xx.xx | $21.13MM | Easton Capital, New Science Ventures | |
Price per Share
$xx.xx
Shares Outstanding
10,590,275
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Easton Capital, New Science Ventures
|
||||||
09/28/2010 | Series Seed | $1.55MM | $xx.xx | $5.15MM | Herb Madan, Akamai Randall Kaplan | |
Price per Share
$xx.xx
Shares Outstanding
1,931,250
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Herb Madan, Akamai Randall Kaplan
|